Anticoagulation therapy in patients with prosthetic heart valves.
Douketis
James D
JD
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
D000925:Anticoagulants / Q000627:therapeutic use; D015897:Comorbidity; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D009369:Neoplasms / Q000209:etiology; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin